Pharmacokinetics of phenol red in rat models of liver damage prepared by liver targeting of carbon tetrachloride

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 4, 2004, Pages 595-597

  Mukai, Takahiro ^a   Mera, Kunihiro ^a   Nishida, Koyo ^a   Nakashima, Mikiro ^a   Sasaki, Hitoshi ^a   Nakamura, Junzo ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Animal model; Carbon tetrachloride; Liver damage; Liver targeting; Pharmacokinetics; Phenol red

Indexed keywords

CARBON TETRACHLORIDE; PHENOLSULFONPHTHALEIN; COLORING AGENT;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG EFFECT; LIVER; LIVER DISEASE; LIVER INJURY; NONHUMAN; RAT; REDUCTION; SURFACE PROPERTY; ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; INTOXICATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; TIME; TOXIC HEPATITIS; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; CARBON TETRACHLORIDE POISONING; COLORING AGENTS; DISEASE MODELS, ANIMAL; HEPATITIS, TOXIC; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; LIVER; MALE; PHENOLSULFONPHTHALEIN; RATS; RATS, WISTAR; TIME FACTORS;

EID: 16544381145     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.595     Document Type: Article

References (24)

1. Koren G., Beatty K., Seto A., Einarson T. R., Lishner M., Ann. Pharmacother., 26, 363-371 (1992).
2. McLean A. J., Morgan D. J., Clin. Pharmacokinet., 21, 42-69 (1991).
3. Díaz-García J. M., Oliver-Botana J., Fos-Galve D., J. Pharm. Sci., 81, 768-772 (1992).
4. Kimura T., Nakayama S., Yamao T., Kurosaki Y., Nakayama T., Biol. Pharm. Bull., 16, 1140-1145 (1993).
5. Shibata N., Shimakawa H., Minouchi T., Yamaji A., Biol. Pharm. Bull., 16, 1130-1135 (1993).
6. Blondé-Cynober F., Plassart F., Rey C., Coudray-Lucas C., Moukarbel N., Poupon R., Giboudeau J., Cynober L., Ann. Nutr. Metab., 38, 238-248 (1994).
7. Pérez Tamayo R., Hepatology, 3, 112-120 (1983).
8. Reuber M. D., Glover E. L., J. Natl. Cancer Inst., 44, 419-427 (1970).
9. Rojkind M., Greenwel P., "Advances in Veterinary Science and Comparative Medicine," Vol. 37, ed. by Cornelius C. E., Academic Press, San Diego, 1993, pp. 333-355.
10. Hirate J., Watanabe J., Ozeki, S., Chem. Pharm. Bull., 32, 2848-2850 (1984).
11. Li C., Nakayama S., Kurosaki Y., Nakayama T., Kimura T., J. Pharmacobio-Dyn., 13, 186-194 (1990).
12. Mukai T., Mera K., Nishida K., Nakashima M., Sasaki H., Sakaeda T., Nakamura J., Biol. Pharm. Bull., 25, 1494-1497 (2002).
13. Striker G. E., Smuckler E. A., Kohnen P. W., Nagle R. B., Am. J. Pathol., 53, 769-789 (1968).
14. Goldring W., Clarke R. W., Smith H. W., J. Clin. Invest., 15, 221-228 (1936).
15. Hart L. G., Schanker L. S., Proc. Soc. Exp. Biol. Med., 123, 433-435 (1966).
16. Yamaoka K., Nakagawa T., Uno T., J. Pharmacokinet. Biopharm., 6, 547-558 (1978).
17. Fleck C., Braunlich H., Pharmacol. Ther., 25, 1-22 (1984).
18. Sugi K., Inoue M., Morino Y., Sato T., Biochim. Biophys. Acta, 987, 217-221 (1989).
19. Kim S. G., Chung H. C., Cho J. Y., J. Pharmacol. Exp. Ther., 277, 1058-1066 (1996).
20. McCay P. B., Lai E. K., Poyer J. L., DuBose C. M., Janzen E. G., J. Biol. Chem., 259, 2135-2143 (1984).
21. McGregor D., Lang M., Mutat. Res., 366, 181-195 (1996).
22. Sanzgiri U. Y., Srivatsan V., Muralidhara S., Dallas C. E., Bruckner J. V., Toxicol. Appl. Pharmacol., 143, 120-129 (1997).
23. Ronis M. J. J., Huang J., Longo V., Tindberg N., Ingelman-Sundberg M., Badger T. M., Biochem. Pharmacol., 55, 123-129 (1998).
24. Shelby M. K., Cherrington N. J., Vansell N. R., Klaassen C. D., Drug Metab. Dispos., 31, 326-333 (2003).